| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-4758(97)01130-7 |
| P698 | PubMed publication ID | 15275155 |
| P2093 | author name string | Weiss N | |
| Lammie PJ | |||
| Weil GJ | |||
| P2860 | cites work | Detection of Wuchereria bancrofti DNA in patients' sputum by the polymerase chain reaction | Q38852622 |
| Evaluation of a recombinant parasite antigen for the diagnosis of lymphatic filariasis. | Q38974024 | ||
| A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis | Q43500659 | ||
| Parasite antigenemia without microfilaremia in bancroftian filariasis. | Q44300320 | ||
| Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. | Q48083899 | ||
| A polymerase chain reaction assay for the detection of Wuchereria bancrofti in blood samples from French Polynesia. | Q52550997 | ||
| Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. | Q52552215 | ||
| Circulating parasite antigen in Brugia pahangi-infected jirds | Q68927754 | ||
| Use of parasite antigen detection to monitor the success of drug therapy in Dirofilaria immitis-infected dogs | Q68929682 | ||
| Effect of CGP 20376 on Brugia malayi and parasite antigenemia in jirds | Q70170000 | ||
| P433 | issue | 10 | |
| P921 | main subject | filariasis | Q815753 |
| Wuchereria bancrofti filariasis | Q16333787 | ||
| P304 | page(s) | 401-404 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Trends in Parasitology | Q15265846 |
| P1476 | title | The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis | |
| P478 | volume | 13 |
| Q53111003 | "Filarial dance sign" real-time ultrasound diagnosis of filarial oophoritis. |
| Q47861453 | A cohort study on anti-filarial IgG4 and its assessment in good and uncertain MDA-compliant subjects in brugian filariasis endemic areas in southern Thailand |
| Q28473329 | A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti |
| Q35689798 | A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration |
| Q28544914 | A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration |
| Q35031867 | A laboratory-based surveillance system for Wuchereria bancrofti in Togo: a practical model for resource-poor settings |
| Q40053734 | A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa |
| Q39346014 | A novel rapid test for detecting antibody responses to Loa loa infections |
| Q36377512 | A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. |
| Q21562257 | A research agenda for helminth diseases of humans: Towards control and elimination |
| Q28472962 | A reverse transcriptase-PCR assay for detecting filarial infective larvae in mosquitoes |
| Q28486145 | A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation |
| Q61800662 | Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis |
| Q24245688 | Albendazole for lymphatic filariasis |
| Q24247486 | Albendazole for lymphatic filariasis |
| Q64125596 | An ELISA kit with two detection modes for the diagnosis of lymphatic filariasis |
| Q39386722 | An evaluation of antigen capture assays for detecting active filarial antigens |
| Q38884367 | An internal control for the detection of Onchocerca volvulus DNA by PCR-ELISA and rapid detection of specific PCR products by DNA Detection Test Strips |
| Q38535058 | An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys |
| Q38993789 | Analysis of Wuchereria bancrofti infections in a village community in northern Nigeria: increased prevalence in individuals infected with Onchocerca volvulus |
| Q28484232 | Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA) |
| Q44449585 | Antigenemia in young children living in Wuchereria bancrofti-endemic areas of Orissa, India |
| Q73489305 | Antigenemia is associated with low antibody response to carbohydrate determinants of a filarial surface antigen |
| Q35234005 | Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific |
| Q42264075 | Are there any factors affecting the outcome of endoscopic sclerotherapy in filarial chyluria? A prospective study |
| Q60053091 | Backpack PCR: A point-of-collection diagnostic platform for the rapid detection of Brugia parasites in mosquitoes |
| Q37820662 | Biosensors as rapid diagnostic tests for tropical diseases |
| Q54989950 | Chiluria in a lymphatic filariasis endemic area. |
| Q40879050 | Circulating filarial antigen detection in brugian filariasis |
| Q39129272 | Circulating microfilariae in haematological malignancies: do they have a role in pathogenesis? |
| Q36398143 | Clinical epidemiology of lymphatic filariasis and community practices and perceptions amongst the ado people of benue state, Nigeria |
| Q33223646 | Cloning and expression of a 12 kDa serospecific epitope of Wuchereria bancrofti |
| Q37166188 | Community-wide distribution of long-lasting insecticidal nets can halt transmission of lymphatic filariasis in southeastern Nigeria |
| Q46784648 | Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens |
| Q36436320 | Comparison of Methods for Xenomonitoring in Vectors of Lymphatic Filariasis in Northeastern Tanzania |
| Q90605022 | Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia |
| Q52593136 | Control of onchocerciasis today: status and challenges. |
| Q83364197 | Cost-effective antigen testing for delimitation, monitoring and evaluation in bancroftian filariasis |
| Q36257596 | Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region |
| Q96126729 | Designing antifilarial drug trials using clinical trial simulators |
| Q33256598 | Detection of Brugia parasite DNA in human blood by real-time PCR. |
| Q35076420 | Detection of Wuchereria bancrofti DNA in paired serum and urine samples using polymerase chain reaction-based systems |
| Q33255108 | Detection of adult Brugia malayi filariae by ultrasonography in humans in India and Indonesia |
| Q39005160 | Detection of filaria-specific IgG4 antibodies and filarial DNA, for the screening of blood spots for Brugia timori |
| Q64055260 | Detection of helminths by loop-mediated isothermal amplification assay: a review of updated technology and future outlook |
| Q50784428 | Development and characterization of monoclonal antibodies against WbSXP-1 for the detection of circulating filarial antigens. |
| Q50768879 | Development and evaluation of a rapid flow-through immuno filtration test using recombinant filarial antigen for diagnosis of brugian and bancroftian filariasis. |
| Q41469016 | Development and testing of a rapid diagnostic test for bubonic and pneumonic plague |
| Q37680704 | Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya |
| Q57459865 | Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil |
| Q50760982 | Development of antigen detection ELISA for the diagnosis of brugian and bancroftian filariasis using antibodies to recombinant filarial antigens Bm-SXP-1 and Wb-SXP-1. |
| Q39485114 | Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas |
| Q36583688 | Diagnosis of a malayan filariasis case using a shotgun diagnostic metagenomics assay. |
| Q28484345 | Diagnosis of brugian filariasis by loop-mediated isothermal amplification |
| Q35572403 | Diagnosis of human filariases (except onchocerciasis). |
| Q38158192 | Diagnosis of human nematode infections |
| Q33580745 | Diagnosis of parasitic diseases: old and new approaches |
| Q37432522 | Distribution of Brugia malayi larvae and DNA in vector and non-vector mosquitoes: implications for molecular diagnostics |
| Q37353097 | Does 24bp Duplication of Human CHIT1 Gene (Chitotriosidase1) Predispose to Filarial Chyluria? A Case-Control Study |
| Q28189876 | Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production |
| Q43544138 | Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. |
| Q44158186 | Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India |
| Q39382405 | Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. |
| Q55638435 | Effects of lyophilization and storage temperature on Wuchereria bancrofti antigen sensitivity and stability |
| Q28482086 | Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti |
| Q33630938 | Elimination of lymphatic filariasis in Southeast Asia |
| Q48512507 | Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary? |
| Q28477441 | Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria |
| Q40146369 | Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control |
| Q42265121 | Epidemiological screening of lymphatic filariasis among immigrants using dipstick colloidal dye immunoassay |
| Q33807325 | Epidemiology and immunopathology of bancroftian filariasis |
| Q34489025 | Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper |
| Q35141239 | Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis |
| Q39322274 | Evaluation of diagnostic tests for Wuchereria bancrofti infection in Brazilian schoolchildren |
| Q33904395 | Evaluation of rapid blood sample collection in the detection of circulating filarial antigens for epidemiological survey by rWbSXP-1 capture assay |
| Q44143470 | Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India |
| Q36929626 | Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection |
| Q54206850 | Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis. |
| Q39548621 | Evaluation of two tests based on the detection of histidine rich protein 2 for the diagnosis of imported Plasmodium falciparum malaria. |
| Q36149626 | Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria |
| Q80178846 | Evidence for the interruption of transmission of lymphatic filariasis among schoolchildren in Trinidad and Tobago |
| Q37491369 | Exploring the immunology of parasitism--from surface antigens to the hygiene hypothesis |
| Q73944787 | Field trial of a rapid card test for Wuchereria bancrofti |
| Q36265533 | Filaria associated clinical manifestations in children in an endemic area and morbidity control by immunomonitoring and optimal DEC therapy: Sevagram experience |
| Q39261692 | Filaria control and elimination: diagnostic, monitoring and surveillance needs |
| Q34640167 | Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo |
| Q36999473 | Filarial/human immunodeficiency virus coinfection in urban southern India |
| Q36226375 | First analysis of the secretome of the canine heartworm, Dirofilaria immitis. |
| Q36875780 | Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi |
| Q92423200 | Genetic association of MBL-2 gene polymorphisms with Filarial chyluria |
| Q53636821 | Global mapping of lymphatic filariasis. |
| Q30395591 | High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic |
| Q35896003 | Histopathologic improvement with lymphedema management, Léogâne, Haiti |
| Q28547873 | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
| Q73518417 | Human infection with Wuchereria bancrofti in Matara, Sri Lanka: the use, in parallel, of an ELISA to detect filaria-specific IgG4 in urine and of ICT card tests to detect filarial antigen in whole blood |
| Q60054253 | Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis |
| Q28484234 | Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection |
| Q36623443 | Immune dynamics in the pathogenesis of human lymphatic filariasis. |
| Q35653141 | Immunodiagnostic Properties of Wucheraria bancrofti SXP-1, a Potential Filarial Diagnostic Candidate Expressed in Tobacco Plant, Nicotiana tabacum. |
| Q44171941 | Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis |
| Q43933955 | Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications |
| Q38940535 | Imported Asymptomatic Bancroftian Filariasis Discovered from a Plasmodium vivax Infected Patient: A Case Report from Singapore |
| Q33703874 | Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration |
| Q33467050 | Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries |
| Q35877618 | Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures |
| Q24801002 | Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity |
| Q37277755 | Lymphatic Filariasis in India : Problems, Challenges and New Initiatives |
| Q57043656 | Lymphatic Filariasis in Mainland Southeast Asia: A Systematic Review and Meta-Analysis of Prevalence and Disease Burden |
| Q37369863 | Lymphatic filariasis in Luangwa District, South-East Zambia |
| Q27692876 | Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011. |
| Q39302776 | Lymphatic filariasis in the Karonga district of northern Malawi: a prevalence survey |
| Q36492737 | Lymphatic filariasis: Treatment, control and elimination |
| Q34368542 | Lymphatic filariasis: an infection of childhood |
| Q34134452 | Lymphatic filariasis: new insights into an old disease |
| Q34151687 | Lymphatic filariasis: setting the scene for elimination |
| Q28547792 | Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination |
| Q24791675 | Mapping of lymphatic filariasis in Nepal |
| Q90113496 | Mapping the baseline prevalence of lymphatic filariasis across Nigeria |
| Q36990294 | Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. |
| Q24813874 | Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity |
| Q35721923 | Mathematical modelling and the control of lymphatic filariasis |
| Q37254795 | Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators. |
| Q36958528 | Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer |
| Q36204671 | Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling |
| Q92914526 | Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India |
| Q28267545 | Neglected tropical diseases |
| Q38223613 | Neglected tropical diseases: now more than just 'other diseases'--the post-2015 agenda |
| Q36441491 | New strategies to combat filariasis |
| Q43948354 | Observations on false positive reactions in the rapid NOW Filariasis card test |
| Q37647885 | Plasma-derived parasitic microRNAs have insufficient concentrations to be used as diagnostic biomarker for detection of Onchocerca volvulus infection or treatment monitoring using LNA-based RT-qPCR. |
| Q42910469 | Post–Kidney Transplantation Lymphocele due to a Lymphatic Filariasis |
| Q47643132 | Preliminary observations on fluids incubated with Wuchereria bancrofti using the immunochromatographic test. |
| Q36622829 | Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia |
| Q40187010 | Production, purification and diagnostic application of filarial recombinant protein WbSXP-1 expressed in salt inducible Escherichia coli |
| Q92524117 | Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities |
| Q46716665 | Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi. |
| Q38413227 | Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi |
| Q30397196 | Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. |
| Q24646797 | Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection |
| Q33615421 | Real-time PCR detection of the HhaI tandem DNA repeat in pre- and post-patent Brugia malayi Infections: a study in Indonesian transmigrants |
| Q34677166 | Recent advances in molecular diagnostic techniques for human lymphatic filariasis and their use in epidemiological research |
| Q24795014 | Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial |
| Q44410987 | Red blood cell antioxidant levels in Wuchereria bancrofti infection |
| Q37726538 | Relevance of the eosinophil blood count in bancroftian filariasis as a screening tool for the treatment |
| Q44147426 | Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia--a longitudinal study |
| Q38849628 | Risk Factors for Podoconiosis: Kamwenge District, Western Uganda, September 2015. |
| Q44818010 | Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India |
| Q44586097 | Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: implications for epidemiological surveillance |
| Q39127761 | Short communication: Negative spatial association between lymphatic filariasis and malaria in West Africa |
| Q78968065 | Short communication: use of a recombinant antigen-based ELISA to determine prevalence of brugian filariasis among Malaysian schoolchildren near Pasir Mas, Kelantan-Thailand border |
| Q44164360 | Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria |
| Q57269716 | Simple blood-spot sampling with nested polymerase chain reaction detection for epidemiology studies on Brugia malayi |
| Q44071632 | Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status |
| Q24791498 | Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence |
| Q58600294 | Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys |
| Q33360876 | Temporal epidemiology of microfilaraemia among migrant workers entering Kuwait |
| Q38087567 | Testicular mass: do not forget filariasis |
| Q34335313 | The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases |
| Q57144504 | The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia? |
| Q35617736 | The application of biomedical engineering techniques to the diagnosis and management of tropical diseases: a review |
| Q36377501 | The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt |
| Q34079359 | The field-testing of a novel integrated mapping protocol for neglected tropical diseases |
| Q36444522 | The geographical distribution of lymphatic filariasis infection in Malawi |
| Q34340088 | The global distribution and transmission limits of lymphatic filariasis: past and present |
| Q28476658 | The impact of a filariasis control program on Lihir Island, Papua New Guinea |
| Q28474163 | The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea |
| Q46390703 | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
| Q59549900 | The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar |
| Q44652881 | The prevalences ofWuchereria bancroftiantigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets |
| Q33719357 | The role of albendazole in programmes to eliminate lymphatic filariasis |
| Q58761280 | The significance of guinea worm infection in the immunological diagnosis of onchocerciasis and bancroftian filariasis |
| Q34566637 | The use of bivariate spatial modeling of questionnaire and parasitology data to predict the distribution of Schistosoma haematobium in Coastal Kenya |
| Q39640022 | The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries |
| Q77711793 | The use of whole blood absorbed on filter paper to detect Wuchereria bancrofti circulating antigen |
| Q45884481 | Touchdown–touchup nested PCR for low-copy gene detection of benzimidazole-susceptible Wuchereria bancrofti with a Wolbachia endosymbiont imported by migrant carriers |
| Q34392618 | Towards elimination of lymphatic filariasis in India |
| Q42577897 | Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? |
| Q50075609 | Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti |
| Q36066068 | Treatment strategies underpinning the global programme to eliminate lymphatic filariasis |
| Q21562277 | Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study |
| Q39095216 | Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection |
| Q34006284 | Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis |
| Q39126799 | Update on Lymphatic Filarial Infections |
| Q39746445 | Urban lymphatic filariasis in central Nigeria |
| Q37362183 | Urban lymphatic filariasis in the metropolis of Dar es Salaam, Tanzania |
| Q46213521 | Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia |
| Q41892096 | Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans |
| Q46582634 | Using the AD12-ICT rapid-format test to detect Wuchereria bancrofti circulating antigens in comparison to Og4C3-ELISA and nucleopore membrane filtration and microscopy techniques |
| Q52733802 | [Filariasis in clinical practice]. |
Search more.